Correlation Between Shuttle Pharmaceuticals and China SXT

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shuttle Pharmaceuticals and China SXT at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shuttle Pharmaceuticals and China SXT into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shuttle Pharmaceuticals and China SXT Pharmaceuticals, you can compare the effects of market volatilities on Shuttle Pharmaceuticals and China SXT and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shuttle Pharmaceuticals with a short position of China SXT. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shuttle Pharmaceuticals and China SXT.

Diversification Opportunities for Shuttle Pharmaceuticals and China SXT

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Shuttle and China is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Shuttle Pharmaceuticals and China SXT Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China SXT Pharmaceuticals and Shuttle Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shuttle Pharmaceuticals are associated (or correlated) with China SXT. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China SXT Pharmaceuticals has no effect on the direction of Shuttle Pharmaceuticals i.e., Shuttle Pharmaceuticals and China SXT go up and down completely randomly.

Pair Corralation between Shuttle Pharmaceuticals and China SXT

Given the investment horizon of 90 days Shuttle Pharmaceuticals is expected to generate 1.99 times more return on investment than China SXT. However, Shuttle Pharmaceuticals is 1.99 times more volatile than China SXT Pharmaceuticals. It trades about -0.17 of its potential returns per unit of risk. China SXT Pharmaceuticals is currently generating about -0.36 per unit of risk. If you would invest  133.00  in Shuttle Pharmaceuticals on August 27, 2024 and sell it today you would lose (46.00) from holding Shuttle Pharmaceuticals or give up 34.59% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Shuttle Pharmaceuticals  vs.  China SXT Pharmaceuticals

 Performance 
       Timeline  
Shuttle Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
China SXT Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China SXT Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Shuttle Pharmaceuticals and China SXT Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shuttle Pharmaceuticals and China SXT

The main advantage of trading using opposite Shuttle Pharmaceuticals and China SXT positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shuttle Pharmaceuticals position performs unexpectedly, China SXT can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China SXT will offset losses from the drop in China SXT's long position.
The idea behind Shuttle Pharmaceuticals and China SXT Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Valuation
Check real value of public entities based on technical and fundamental data